Compare Figs Inc (FIGS) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Figs Inc vs Nomura Holdings Inc — how do they compare? Figs Inc trades at $15.78 (market cap $2.49B), while Nomura Holdings Inc trades at $9.59 (market cap $27.55B). The key difference: Nomura Holdings Inc is far larger — about 11.1× Figs Inc's market cap, and Nomura Holdings Inc pays a 3.4% dividend while Figs Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Figs Inc for 33 Days and Nomura Holdings Inc for 55 Days on average.
| FIGS | NMR | |
|---|---|---|
Market Cap | $2.49B | $27.55B |
Volume | 5,964,311 | 782,470 |
Sector | Consumer Cyclical | Financials |
52-Week High | $17.12 | $10.86 |
52-Week Low | $6.90 | $6.73 |
Typical Hold Time | 33 Days | 55 Days |
Enterprise Value | $2.25B | $38.54T |
Dividend Yield | — | 3.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FIGS stock trades at $14.98, up 6.54% in the last session, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $631.10M in 2025, with net income reaching $34.25M, and the company has raised its 2026 outlook. The stock shows momentum with a consensus price target of $18.00, indicating potential upside from current levels.
The outlook for FIGS is positive, driven by accelerating revenue growth, expanding international sales, and improving margins. Key risks include its premium valuation and execution challenges in sustaining growth. Analyst sentiment is predominantly bullish, supporting a favorable investment case for growth-oriented investors.
Nomura Holdings (NMR) trades at $9.54, up 0.1% on the day, with a bearish technical signal but strong fundamental metrics including a P/E of 11.33 and net income margin of 20.4%. Recent earnings show a mix of beats and misses, while cash flow trends indicate significant financing activity. The stock is near its support level of $9, with RSI indicators suggesting potential oversold conditions. Zacks Research highlighted NMR as a strong buy for momentum and value in September 2026, citing recent price strength.
The outlook for NMR is cautiously optimistic, supported by solid profitability and valuation, but tempered by bearish technicals and inconsistent earnings performance. Key risks include high debt levels and macroeconomic sensitivity, while analyst sentiment leans hold. Upside potential exists if earnings stabilize and technical support holds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Figs Inc
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
